46 results on '"Baldus, Stephan"'
Search Results
2. TCT-288 Implantation Depth and Need for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the JenaValve System in Patients With Severe Aortic Regurgitation
3. TCT-163 Artificial Intelligence-Enabled Assessment of Right Ventricular to Pulmonary Artery Coupling Refines Mortality Prediction in Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention
4. 6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation
5. Percutaneous Mitral Valve Interventions in the Real World: Early and 1-Year Results From the ACCESS-EU, A Prospective, Multicenter, Nonrandomized Post-Approval Study of the MitraClip Therapy in Europe
6. TCT-166 Concomitant Mitral Regurgitation and Low-Gradient Aortic Stenosis in Patients Undergoing TAVR or SAVR—An Analysis From the German Aortic Valve Registry (GARY)
7. 30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS
8. TCT CONNECT-488 Two-Year Outcomes of the TRI-REPAIR Study Assessing the Cardioband Tricuspid Valve Reconstruction System for Patients With Functional Tricuspid Regurgitation
9. TCT CONNECT-333 German Multicenter Experience With a New Leaflet-Based Transcatheter Mitral Valve Repair System for Mitral Regurgitation
10. IMPACT OF PROPORTIONALITY OF SECONDARY MITRAL REGURGITATION ON OUTCOME AFTER TRANSCATHETER MITRAL VALVE REPAIR
11. TCT-373 LAA Occlusion With the Amplatzer and AMULET Devices: Long-Term Outcomes in a High-Risk Cohort
12. TCT-42 An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)
13. TCT-41 Acute and Six-month Outcomes of a Novel Self-expanding Transcatheter Heart Valve
14. TCT-56 Transcatheter Mitral Valve Repair in Patients with Functional Mitral Regurgitation – One-Year Outcomes from the Multicenter CE Trial
15. MULTICENTER TRIAL OF A TRANSFEMORAL SYSTEM FOR MITRAL VALVE ANNULOPLASTY: UP-TO-2-YEAR FOLLOW-UP RESULTS
16. TCT-41 Up to two years follow up results of mitral valve transcatheter annuloplasty system for mitral reconstruction multi-center trial
17. FUNCTIONAL IMPROVEMENT ANALYSIS 1 YEAR AFTER PER-CUTANEOUS MITRAL VALVE REPAIR
18. UP TO ONE-YEAR FOLLOW-UP RESULTS FROM A MULTICENTER TRIAL OF A TRANSFEMORAL SYSTEM FOR MITRAL VALVE RECONSTRUCTION
19. EFFECT OF TRANSCATHETER MITRAL REPAIR WITH THE CARDIOBAND DEVICE ON 3-DIMENSIONAL GEOMETRY OF THE MITRAL ANNULUS
20. TCT-110 Up to One Year Follow Up Results of Transcatheter Annuloplasty Ring Multicentre Trial
21. PERCUTANEOUS MITRAL VALVE DIRECT ANNULOPLASTY WITH A “SURGICAL-LIKE” RING: RESULTS FROM MULTICENTRE FIRST-IN-MAN FEASIBILITY TRIAL
22. ACUTE AND MID-TERM RESULTS FROM A FIM/APPROVAL TRIAL OF A 2ND GENERATION TRANSFEMORAL AORTIC BIOPROSTHESIS FOR THE TREATMENT OF PATIENTS WITH SEVERE AORTIC STENOSIS
23. TCT-90 MitraClip Therapy in Patients at High Surgical Risk: Classification Tree Analysis to Reveal the Interrelation of Baseline Echocardiographic Variables Impacting Acute Procedural Outcome
24. TCT-91 MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation
25. TCT-695 A Gender-Specific Look at MitraClip Therapy in Surgical High-Risk Patients: Acute and Long-Term Outcomes
26. TCT-86 The 2011-12 Pilot European Sentinel Registry of Percutaneous Edge-to-Edge Mitral Valve Repair: In-hospital results and mid-term follow up of 587 patients
27. TCT-763 A Risk Prediction Algorithm for 1-Year Mortality after Transcatheter Aortic Valve Implantation
28. INTERVENTIONAL MITRAL VALVE REPAIR USING THE MITRACLIP SYSTEM AFTER PRIOR SURGICAL MITRAL ANNULOPLASTY
29. TCT-849 Predictive reliability of logistic EuroSCORE II in patients undergoing transcatheter aortic valve implantation: assessment and comparison to classic systems of preoperative risk stratification
30. TCT-791 Percutaneous or surgical repair for functional mitral regurgitation – comparison of patient characteristics and clinical outcomes
31. TCT-790 Prediction of long-term clinical outcome according to the etiology of mitral regurgitation in patients undergoing MitraClip therapy
32. TCT-102 Transapical Aortic Valve Implantation: 6 and 12 Months Results From a Multicenter Study Using the JenaValve Second Generation Transcatheter Aortic Valve Implantation System
33. TCT-783 Successful MitraClip Therapy in Elderly Patients not Amenable to Surgery: Serial Assessment of Echocardiographic and Clinical Variables out to 2 Years
34. TCT-780 Baseline Systolic Left Ventricular Function Determines Hemodynamic Adaptation Following Percutaneous Mitral Valve Repair - Assessment By Conductance Catheter
35. TRANSAPICAL AORTIC VALVE IMPLANTATION (TA-AVI) USING A NEW SELF-EXPANDABLE BIOPROSTHESIS (ACURATE TA(TM)): MIDTERM OUTCOMES IN 90 PATIENTS
36. ACCESS EUROPE: A POST MARKET STUDY OF THE MITRACLIP SYSTEM FOR THE TREATMENT OF SIGNIFICANT MITRAL REGURGITATION (MR) IN EUROPE: ANALYSIS OF OUTCOMES AT 6-MONTHS
37. MITRAL REGURGITATION OF DEGENERATIVE AS OPPOSED TO FUNCTIONAL ORIGIN NEGATIVELY IMPACTS OUTCOMES OF MITRACLIP THERAPY: SINGLE-CENTER EXPERIENCE WITH 255 CONSECUTIVE PATIENTS
38. MYELOPEROXIDASE AS EARLY DIAGNOSTIC AND PROGNOSTIC MARKER OF ACUTE CORONARY SYNDROME: A HEAD-TO-HEAD COMPARISON WITH HIGH SENSITIVE TROPONIN I
39. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
40. MULTIMARKER RISK MODEL CONTAINING TROPONIN, INTERLEUKIN-10, MYELOPEROXIDASE AND PLACENTAL GROWTH FACTOR PREDICTS LONG-TERM CARDIOVASCULAR RISK AFTER NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
41. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts
42. Six-month clinical and angiographic outcome after successful excimer laser angioplasty for in-stent restenosis
43. Captopril reduces endothelin-1 release from human umbilical vein endothelial cells by reduction of angiotensin II synthesis
44. Captopril reduces endothelin-1 release from human umbilical vein endothelial cells by reduction of angiotensin II synthesis
45. Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation.
46. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.